The Hospital Unit of Eurofarma is one of the leaders in this important segment. It promotes and markets a broad portfolio of medicines and parenteral solutions of large volume (LVPS), high-tech products and high quality standard. It directly serves over 1,800 hospitals and distributors through a robust distribution network covering the entire national territory.
The portfolio of products totaling more than 5 million units annually sold. In 2015, the unit launched into the market two medications designed to treat grievous hospital infections – antibiotics Linezolid and Moxifloxacin Hydrochloride.